Cases - Business

Accounts Receivable Financing and Accounts Receivable Factoring are two terms that are i

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

nterchangeably used, but there is a major difference between them. Although both refer t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

o the concept of extending cash to an owner of a business in lieu of invoices and other

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Accounts Receivable, there are differences, no matter how subtle.

First of all, Account

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s Receivable Financing is a loan in which the invoices are used as collateral. But this

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

not the case with Accounts Receivable Factoring. Accounts Receivable Factoring is not a

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

loan. It involves the selling of the invoices to the financing company at a rate less th

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

n the face value of the invoices. The financing companies then collect the money at the

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

full face value from the clients. This means the business no longer has the responsibili

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ty of collecting the money.

But this is not the case in Accounts Receivable Financing.

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

The process of Financing involves the extension of an advance on the percentage of each

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

invoice??bf?s amount. Also, the responsibility of collecting the money remains with the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

business house.

Both Account Receivable Funding and Financing companies charge addition

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

al fees for services rendered, but in case of Account Receivable Factoring, the fees cha

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ged are comparatively higher. This is mainly because the entire responsibility of collec

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ting the money is with the financing company.

Companies providing Account Receivable Fi

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

nancing step in and work with companies who cannot get loans otherwise. Account Receivab

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

le Factoring, on the other hand, proves useful to business houses urgently in need of re

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ady cash flow.

This said, both Account Receivable Factoring and Financing prove extreme

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ly convenient to companies who urgently require a cash flow to keep their business going

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.cases.org.ua/article/3881/cases-Accounts-Receivable-Financing.html">Accounts Receivable Financing</a>

BB link (for phorums):
[url=http://www.cases.org.ua/article/3881/cases-Accounts-Receivable-Financing.html]Accounts Receivable Financing[/url]

One needs to appropriately pack the goods with the right shipping boxes. There are lots to choose from, and you can either purchase this from the shipping company that will ship the goods for you, or you can purchase this from other stores. You can try checking out the Internet for such retailers, as there are now many who have online stores where you can order online – this would make your purchasing a lot easier.

Interested in saving money on your packaging costs? Find out if using plastic corrugated returnable packaging instead of expendable paper packaging is right for your company!

If you have recently implemented Six Sigma in your organization, you need to have a way to assess its success. This article gives you a step-by-step guide to assessing Six Sigma.

Tags

Links

Cases - Accounts Receivable Financing

Related Articles: